CD59a deficient mice display reduced B cell activity and antibody production in response to T-dependent antigens

Molecular Immunology

Volumn 44, Issue 11, 2007, Pages 2978-2987

  Sivasankar, Baalasubramanian ^a   Donev, Rossen M ^a   Longhi, M Paula ^a   Hughes, Timothy R ^a   Davies, Ruth ^a   Cole, Duncan S ^a   Morgan, B Paul ^a   Marchbank, Kevin J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

B cells; Complement; Rodent; T cells

Indexed keywords

CD59 ANTIGEN; HYBRID PROTEIN; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; HUMORAL IMMUNITY; LYMPHOCYTE FUNCTION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEEP ERYTHROCYTE;

ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; ANTIGENS, CD4; ANTIGENS, CD59; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE DELETION; LYMPHOCYTE ACTIVATION; MICE; PROTEIN BINDING;

MUS; OVIS ARIES; RODENTIA;

EID: 33947131639     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.12.025     Document Type: Article

References (48)

1. Baalasubramanian S., Harris C.L., Donev R.M., Mizuno M., Omidvar N., Song W.C., and Morgan B.P. CD59a is the primary regulator of membrane attack complex assembly in the mouse. J. Immunol. 173 (2004) 3684-3692
2. Balazs M., Martin F., Zhou T., and Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17 (2002) 341-352
3. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., Liu Y.J., Rousset F., and Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12 (1994) 881-922
4. Birrell L., Kulik L., Morgan B.P., Holers V.M., and Marchbank K.J. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens. J. Immunol. 174 (2005) 6974-6982
5. Buhlmann J.E., Foy T.M., Aruffo A., Crassi K.M., Ledbetter J.A., Green W.R., Xu J.C., Shultz L.D., Roopesian D., Flavell R.A., et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2 (1995) 645-653
6. Cassese G., Arce S., Hauser A.E., Lehnert K., Moewes B., Mostarac M., Muehlinghaus G., Szyska M., Radbruch A., and Manz R.A. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171 (2003) 1684-1690
7. Crawford A., Macleod M., Schumacher T., Corlett L., and Gray D. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J. Immunol. 176 (2006) 3498-3506
8. Crivellato E., Vacca A., and Ribatti D. Setting the stage: an anatomist's view of the immune system. Trends Immunol. 25 (2004) 210-217
9. Deckert M., Kubar J., and Bernard A. CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. J. Immunol. 148 (1992) 672-677
10. Deckert M., Kubar J., Zoccola D., Bernard-Pomier G., Angelisova P., Horejsi V., and Bernard A. CD59 molecule: a second ligand for CD2 in T cell adhesion. Eur. J. Immunol. 22 (1992) 2943-2947
11. Del Nagro C.J., Kolla R.V., and Rickert R.C. A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis. J. Immunol. 175 (2005) 5379-5389
12. Ferguson A.R., Youd M.E., and Corley R.B. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int. Immunol. 16 (2004) 1411-1422
13. Garside P., Ingulli E., Merica R.R., Johnson J.G., Noelle R.J., and Jenkins M.K. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281 (1998) 96-99
14. Ghiran I., Klickstein L.B., and Nicholson-Weller A. Calreticulin is at the surface of circulating neutrophils and uses CD59 as an adaptor molecule. J. Biol. Chem. 278 (2003) 21024-21031
15. Guinamard R., Okigaki M., Schlessinger J., and Ravetch J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1 (2000) 31-36
16. Hahn W.C., Menu E., Bothwell A.L., Sims P.J., and Bierer B.E. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256 (1992) 1805-1807
17. Harris C.L., Hanna S.M., Mizuno M., Holt D.S., Marchbank K.J., and Morgan B.P. Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison. Immunology 109 (2003) 117-126
18. Holt D.S., Botto M., Bygrave A.E., Hanna S.M., Walport M.J., and Morgan B.P. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98 (2001) 442-449
19. Holt D.S., Powell M.B., Rushmere N.K., and Morgan B.P. Genomic structure and chromosome location of the gene encoding mouse CD59. Cytogenet. Cell Genet. 89 (2000) 264-267
20. Kimberley F.C., Sivasankar B., and Paul Morgan B. Alternative roles for CD59. Mol. Immunol. (2006)
21. Korty P.E., Brando C., and Shevach E.M. CD59 functions as a signal-transducing molecule for human T cell activation. J. Immunol. 146 (1991) 4092-4098
22. Lebman D.A., and Edmiston J.S. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect. 1 (1999) 1297-1304
23. Lenschow D.J., Sperling A.I., Cooke M.P., Freeman G., Rhee L., Decker D.C., Gray G., Nadler L.M., Goodnow C.C., and Bluestone J.A. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153 (1994) 1990-1997
24. Liversidge J., Dawson R., Hoey S., McKay D., Grabowski P., and Forrester J.V. CD59 and CD48 expressed by rat retinal pigment epithelial cells are major ligands for the CD2-mediated alternative pathway of T cell activation. J. Immunol. 156 (1996) 3696-3703
25. Longhi M.P., Sivasankar B., Omidvar N., Morgan B.P., and Gallimore A. Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner. J. Immunol. 175 (2005) 7098-7102
26. Matsuuchi L., and Gold M.R. New views of BCR structure and organization. Curr. Opin. Immunol. 13 (2001) 270-277
27. McIntyre T.M., Klinman D.R., Rothman P., Lugo M., Dasch J.R., Mond J.J., and Snapper C.M. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J. Exp. Med. 177 (1993) 1031-1037
28. Mead R.J., Neal J.W., Griffiths M.R., Linington C., Botto M., Lassmann H., and Morgan B.P. Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis. Lab. Invest. 84 (2004) 21-28
29. Morgan B.P. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem. J. 264 (1989) 1-14
30. Morgan B.P., and Harris C.L. Complement Regulatory Proteins (1999), Academic Press, London, UK
31. Morgan B.P., van den Berg C.W., Davies E.V., Hallett M.B., and Horejsi V. Cross-linking of CD59 and of other glycosyl phosphatidylinositol-anchored molecules on neutrophils triggers cell activation via tyrosine kinase. Eur. J. Immunol. 23 (1993) 2841-2850
32. Oliver A.M., Martin F., Gartland G.L., Carter R.H., and Kearney J.F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27 (1997) 2366-2374
33. Oliver A.M., Martin F., and Kearney J.F. Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J. Immunol. 158 (1997) 1108-1115
34. Oliver A.M., Martin F., and Kearney J.F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162 (1999) 7198-7207
35. Omidvar N., Wang E.C., Brennan P., Longhi M.P., Smith R.A., and Morgan B.P. Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity. J. Immunol. 176 (2006) 2915-2923
36. Pizzo P., Giurisato E., Tassi M., Benedetti A., Pozzan T., and Viola A. Lipid rafts and T cell receptor signaling: a critical re-evaluation. Eur. J. Immunol. 32 (2002) 3082-3091
37. Qian Y.M., Qin X., Miwa T., Sun X., Halperin J.A., and Song W.C. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59. J. Immunol. 165 (2000) 2528-2534
38. Qin X., Dobarro M., Bedford S.J., Ferris S., Miranda P.V., Song W., Bronson R.T., Visconti P.E., and Halperin J.A. Further characterization of reproductive abnormalities in mCd59b knockout mice: a potential new function of mCd59 in male reproduction. J. Immunol. 175 (2005) 6294-6302
39. Ridderstad A., and Tarlinton D.M. Kinetics of establishing the memory B cell population as revealed by CD38 expression. J. Immunol. 160 (1998) 4688-4695
40. Rodriguez-Pinto D. B cells as antigen presenting cells. Cell Immunol. (2006)
41. Rosse W.F. Paroxysmal nocturnal hemoglobinuria. Curr. Top. Microbiol. Immunol. 178 (1992) 163-173
42. Ruprecht C.R., and Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur. J. Immunol. 36 (2006) 810-816
43. Schweitzer A.N., and Sharpe A.H. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J. Immunol. 161 (1998) 2762-2771
44. Snapper C.M., Marcu K.B., and Zelazowski P. The immunoglobulin class switch: beyond "accessibility". Immunity 6 (1997) 217-223
45. Song H., and Cerny J. Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J. Exp. Med. 198 (2003) 1923-1935
46. Weber G.F. The absence of CD44 ameliorates Fas(lpr/lpr) disease. Autoimmunity 37 (2004) 1-8
47. Williams A.S., Mizuno M., Richards P.J., Holt D.S., and Morgan B.P. Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis. Arthritis Rheum. 50 (2004) 3035-3044
48. Zandvoort A., and Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin. Exp. Immunol. 130 (2002) 4-11